LLY

748.42

+1.7%↑

JNJ

177.03

-0.47%↓

ABBV

209.99

+0.36%↑

UNH

348.72

+8.76%↑

NVO

53.9

-0.77%↓

LLY

748.42

+1.7%↑

JNJ

177.03

-0.47%↓

ABBV

209.99

+0.36%↑

UNH

348.72

+8.76%↑

NVO

53.9

-0.77%↓

LLY

748.42

+1.7%↑

JNJ

177.03

-0.47%↓

ABBV

209.99

+0.36%↑

UNH

348.72

+8.76%↑

NVO

53.9

-0.77%↓

LLY

748.42

+1.7%↑

JNJ

177.03

-0.47%↓

ABBV

209.99

+0.36%↑

UNH

348.72

+8.76%↑

NVO

53.9

-0.77%↓

LLY

748.42

+1.7%↑

JNJ

177.03

-0.47%↓

ABBV

209.99

+0.36%↑

UNH

348.72

+8.76%↑

NVO

53.9

-0.77%↓

Search

Alcon Inc

Aperta

SettoreSettore sanitario

79.08 -0.38

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

78.81

Massimo

80.04

Metriche Chiave

By Trading Economics

Entrata

-167M

183M

Vendite

123M

2.6B

P/E

Media del settore

36.949

35.733

Rendimento da dividendi

0.42

Margine di Profitto

7.058

Dipendenti

25,000

EBITDA

-213M

250M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+23.1% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

0.42%

3.13%

Utili prossimi

11 nov 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-4.3B

40B

Apertura precedente

79.46

Chiusura precedente

79.08

Notizie sul Sentiment di mercato

By Acuity

10%

90%

13 / 371 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Bullish Evidence

Alcon Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

2 set 2025, 23:07 UTC

Acquisizioni, Fusioni, Takeovers

Broadwood Partners Plans to Vote Against Staar Sale to Alcon

20 ago 2025, 17:21 UTC

Utili
I principali Market Mover

Alcon Shares Sink After Cut to Fiscal Year Sales Guidance

20 ago 2025, 08:46 UTC

Utili
I principali Market Mover

Alcon Shares Fall After Guidance Trim on U.S. Trade Tariff Hit

5 ago 2025, 10:10 UTC

Acquisizioni, Fusioni, Takeovers

Alcon to Buy Staar Surgical for $1.5 Billion

14 mag 2025, 15:56 UTC

Utili
I principali Market Mover

Alcon Shares Fall After Lowering 2025 Outlook

26 mar 2025, 21:22 UTC

Acquisizioni, Fusioni, Takeovers

Alcon Buys Majority Stake in Aurion to Advance Eye Disease Treatment

20 ago 2025, 17:06 UTC

Utili
I principali Market Mover

Alcon Shares Sink After Cut to FY Sales Guidance

19 ago 2025, 20:32 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Alcon Cuts 2025 View To Sales $10.3B-$10.4B >ALC.EB

19 ago 2025, 20:31 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Alcon 2Q EPS 35c >ALC.EB

19 ago 2025, 20:30 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Alcon 2Q Sales $2.58B >ALC.EB

19 ago 2025, 20:30 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Alcon Reports Second-Quarter 2025 Results, Launched Tryptyr And Announced Acquisition Of STAAR Surgical >ALC

8 ago 2025, 13:40 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Staar Surgical's Top Holder Questions Deal -- Market Talk

5 ago 2025, 05:07 UTC

Acquisizioni, Fusioni, Takeovers

Alcon Deal Puts STARR Equity Value at Approximately $1.5 Billion. >ALC.EB

5 ago 2025, 05:07 UTC

Acquisizioni, Fusioni, Takeovers

Alcon Will Purchase All Outstanding Shares of STAAR Common Stock for $28 Per Share in Cash >ALC.EB

5 ago 2025, 05:07 UTC

Acquisizioni, Fusioni, Takeovers

Alcon Deal Represents 51% Premium to Closing Price of STAAR Common Stock on Aug. 4 >ALC.EB

5 ago 2025, 05:07 UTC

Acquisizioni, Fusioni, Takeovers

Alcon Agrees to Acquire STAAR Surgical >ALC STAA

5 ago 2025, 05:01 UTC

Acquisizioni, Fusioni, Takeovers

Alcon Agrees To Acquire STAAR Surgical >ALC STAA

7 lug 2025, 12:00 UTC

Acquisizioni, Fusioni, Takeovers

Alcon To Acquire LumiThera And Its Photobiomodulation Device For The Treatment Of Early And Intermediate Dry Age-Related Macular Degeneration (AMD) >ALC

30 mag 2025, 06:32 UTC

Discorsi di Mercato
Utili

Alcon's First FDA Approval Since Listing Is Positive, But Expected -- Market Talk

22 mag 2025, 20:46 UTC

Acquisizioni, Fusioni, Takeovers

Alcon and Lensar Receive FTC Requests for Additional Information About Merger

13 mag 2025, 20:32 UTC

Utili

Alcon Raises 2025 View To Sales $10.4B-$10.5B >ALC.EB

13 mag 2025, 20:31 UTC

Utili

Alcon 1Q Sales $2.45B >ALC.EB

13 mag 2025, 20:30 UTC

Utili

Alcon 1Q Rev $2.47B >ALC.EB

13 mag 2025, 20:30 UTC

Utili

Alcon 1Q EPS 70c >ALC.EB

8 apr 2025, 08:20 UTC

Discorsi di Mercato

Med-Tech Investors Seek 'Safe Havens' Amid Tariff Fears -- Market Talk

26 mar 2025, 21:55 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Alcon Deal for Aurion Follows 2022 Investment, 2024 Lawsuit -- Market Talk

26 mar 2025, 20:33 UTC

Acquisizioni, Fusioni, Takeovers

Aurion Board Appoints Arnaud Lacoste as CEO of Aurion

26 mar 2025, 20:32 UTC

Acquisizioni, Fusioni, Takeovers

Alcon: Aurion Will Operate as a Separate Company With Full Support From Alcon to Advance Its Clinical-Stage Allogeneic Cell Therapy Asset

26 mar 2025, 20:32 UTC

Acquisizioni, Fusioni, Takeovers

Leverages Alcon's Global Scale With Aurion's Cell Therapy Expertise to Accelerate U.S. Phase 3 Development in Fall of 2025 >ALC.EB

26 mar 2025, 20:31 UTC

Acquisizioni, Fusioni, Takeovers

Alcon Acquires Interest in Aurion to Advance Innovative Cell Therapy for Corneal Endothelial Disease >ALC.EB

Confronto tra pari

Modifica del prezzo

Alcon Inc Previsione

Obiettivo di Prezzo

By TipRanks

23.1% in crescita

Previsioni per 12 mesi

Media 98.69 USD  23.1%

Alto 119.067 USD

Basso 77.53 USD

Basato su 18 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Alcon Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

18 ratings

13

Acquista

5

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

95.77 / 97.61Supporto e resistenza

A breve termine

Bullish Evidence

A termine intermedio

Strong Bullish Evidence

A lungo termine

Strong Bullish Evidence

Sentiment

By Acuity

13 / 371 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste molto forti

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Alcon Inc

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
help-icon Live chat